MHC-BOUND, SIV-DERIVED, CTL AND HTL EPITOPES
MHC-BOUND, SIV-DERIVED, CTL AND HTL EPITOPES
批准号:
7716392
负责人:
David I Watkins
金额:
$16.38万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-23 至 2009-04-30
关键词:
AllelesAnimalsArginineBindingCD4 Positive T LymphocytesCell LineComputer Retrieval of Information on Scientific Projects DatabaseDataDevelopmentEpitopesFundingGene FrequencyGrantHIVHIV vaccineHelper-Inducer T-LymphocyteHumanImmune responseImmunogeneticsInfectionInstitutionLeucineMHC Class I GenesMacacaMacaca mulattaMapsPeptidesPositioning AttributePublishingReagentResearchResearch PersonnelResourcesSIVServicesSourceStaining methodStainsTestingUnited States National Institutes of HealthWorkcohortcytokinecytotoxicenzyme linked immunospot assaynovelpreferencevirology
中文摘要
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
To work on developing a vaccine for HIV, we will identify additional epitopes for cytotoxic and helper T cells and use this information to develop unique reagents for following immune responses.
The preliminary binding motif of Mamu-B*08 has been determined and shown to contain a dominant preference for arginine at the P2 anchor position along with a dominant preference for leucine at the P9 C-terminus. Currently, a detailed peptide binding motif is being defined. Nine novel SIV derived peptide epitopes restricted by Mamu-B*08 have been identified, while three other regions are currently being mapped to minimal optimal epitopes. These have been mapped by a combination of intracellular cytokine staining and ELISPOT in responder cell lines or PBMC's derived from animals that are elite controllers (and some progressors) of a highly pathogenic SIVmac239 infection. MHC class I tetramers have been successfully produced and verified for 9 minimal optimal Mamu-B*08 epitopes (eight of which have been published). Three other MHC class I tetramers are under development. It is important to note that MHC typing data shows that Mamu-B*08 is over represented among a cohort of rhesus macaques that control SIVmac239 infection. While the overall frequency of this allele in a cohort of 196 WNPRC macaques infected with SIVmac239 is 5.6% (11 of 196), the frequency of this allele among elite controllers is 37.5% (6 of 16). Furthermore, the binding motif of the Mamu-B*08 allele is similar to that of HLA-B*27, an allele in humans associated with control of HIV. Additional testing is currently ongoing to investigate how close the peptide binding motif is between these two alleles. This research used WNPRC Immunogenetics & Virology Services and Animal Services.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
-
批准号:10422995
-
项目类别:
-
资助金额:$99.94万
-
财政年份:2021
-
负责人:David I Watkins
-
依托单位:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
-
批准号:10669613
-
项目类别:
-
资助金额:$97.87万
-
财政年份:2021
-
负责人:David I Watkins
-
依托单位:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
-
批准号:10463875
-
项目类别:
-
资助金额:$98.85万
-
财政年份:2021
-
负责人:David I Watkins
-
依托单位:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
-
批准号:8787712
-
项目类别:
-
资助金额:$61.94万
-
财政年份:2014
-
负责人:David I Watkins
-
依托单位:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
-
批准号:8976140
-
项目类别:
-
资助金额:$53.0万
-
财政年份:2014
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8497605
-
项目类别:
-
资助金额:$214.55万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Protective Immunity
-
批准号:8307106
-
项目类别:
-
资助金额:$51.45万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8688135
-
项目类别:
-
资助金额:$194.7万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8301117
-
项目类别:
-
资助金额:$215.84万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8874851
-
项目类别:
-
资助金额:$195.69万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
DEVELOPMENT OF IMMUNE MONITORING REAGENTS AND MHC TYPING TECHNOLOGIES
-
批准号:8358206
-
项目类别:
-
资助金额:$63.15万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT
-
批准号:8358204
-
项目类别:
-
资助金额:$23.83万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
IMMUNOGENICITY AND PROTECTION OF LIVE ATTENUATED SIV239 DELTA NEF IN RHESUS
-
批准号:8358203
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
MINIGENE VACCINATION WITH EARLY PRESENTED VIRAL PROTEINSAIDS RELATED RESEARCH
-
批准号:8358214
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
SIV-specific Mamu-E-restricted CD8+ T cells
-
批准号:8071437
-
项目类别:
-
资助金额:$20.43万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
CRYPTIC ORFS AS A VACCINE FOR HIV
-
批准号:8358237
-
项目类别:
-
资助金额:$5.96万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
PROTECTIVE EFFICACY OF MERCK AD5 PRIME/BOOST AGAINST MUCOSAL CHALLENGE
-
批准号:8358247
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
VACCINE REGIMENS TO INDUCE CD4+ AND CD8+ T CELLS AGAINST SIV EPITOPES
-
批准号:8358223
-
项目类别:
-
资助金额:$9.53万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
SIV-specific Mamu-E-restricted CD8+ T cells
-
批准号:8212162
-
项目类别:
-
资助金额:$21.64万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
MHC TYPING OF MACAQUES USED IN AIDS RESEARCH
-
批准号:8358202
-
项目类别:
-
资助金额:$28.59万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
海外基金